Last updated on June 2018

Optimal Research is enrolling healthy adults ages 18-45 for a vaccine research study for the Chikungunya virus. Compensation may be provided to qualified participants up to $1550.00 for this 13 visit study.


Brief description of study

Chikungunya Vaccine research study lasts 13 visits. Compensation may be provided to qualified participants up to $1550.00.

Clinical Study Identifier: TX202129

Find a site near you

Start Over

Optimal Research Huntsville

2089 Cecil Ashburn Drive, Suite 203 Huntsville, AL USA
  Connect »